Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in Vitro binding neutralization properties

Virology

Volumn 249, Issue 1, 1998, Pages 32-41

  Habersetzer, François ^a   Fournillier, Anne ^a   Dubuisson, Jean ^b   Rosa, Domenico ^c   Abrignani, Sergio ^c   Wychowski, Czeslaw ^b   Nakano, Isao ^a   Trépo, Christian ^a   Desgranges, Claude ^a   Inchauspé, Geneviève ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c CHIRON VACCINES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIGEN; HUMAN MONOCLONAL ANTIBODY; VIRUS GLYCOPROTEIN;

ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL IMMORTALIZATION; EPSTEIN BARR VIRUS; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; RNA VIRUSES;

EID: 0032530620     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9202     Document Type: Article

References (51)

1. Abrignani S. Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin. Immunopathol. 19:1997;47-55.
2. Akatsuka T., Donets M., Scaglione L., Ching W. M., Shih J. W-K., Di Bisceglie A. M., Feinstone S. M. B-cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies. Hepatology. 18:1993;503-510.
3. Bergeron J. J. M., Brenner M. B., Thomas D. Y., Williams D. B. Calnexin: A membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 19:1994;124-129.
4. Bhattacherjee V., Prescot L. E., Pike I., Rodgers B., Bell H., El-Zayadi A. R., Kew M. C., Conradie J., Lin C. K., Mardsen H., Saeed A. A., Parker D., Yap P.-L., Simmonds P. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J. Gen. Virol. 76:1995;1737-1748.
5. Boyer V., Broly H., Souche S., Madaule P., Rossier J., Zagury D., Desgranges C. Characterization and large production of human monoclonal antibodies against the HIV-1 envelope. Clin. Exp. Immunol. 83:1991;452-459.
6. Bredenbeek P. J., Frolov I., Rice C. M., Schlesinger S. Sindbis virus expression vector: Packaging of RNA replicons by using defective helper RNAs. J. Virol. 67:1993;6439-6446.
7. Bukh J., Purcell R. H., Miller R. H. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. USA. 89:1992;4942-4946.
8. Cerino A., Mondelli M. U. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies. J. Immunol. 147:1991;2692-2696.
9. Cerino A., Boender P., La Monica N., Rosa C., Habets W., Mondelli M. U. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein. J. Immunol. 151:1993;7005-7015.
10. Chan S.-W., Bye J. M., Jackson P., Allain J. P. Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library. J. Gen. Virol. 77:1996;2531-2539.
11. Chien D. Y., Choo Q.-L., Ralston R., Spaete R., Tong M., Houghton M., Kuo G. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet. 342:1993;933.
12. Choo Q.-L., Kuo G., Ralston R., Weiner A., Chien D., Van Nest G., Han J., Berger K., Thudium K., Kuo C., Kansopon J., McFarland J., Tabrizi A., Ching K., Moss B., Lummins L. B., Houghton M., Muchmore R. E. E. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 91:1994;1294-1298.
13. Choo Q.-L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
14. Conley A. J., Kesseler J. A., Boots L. J., McKenna P. M., Schleif W. A., Emini E. A., Mark G. E. III, Katinger H., Cobb E. K., Lunceford S. M., Rouse S. R., Murthy K. K. The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary isolate. J. Virol. 70:1996;6751-6758.
15. Deleersnyder V., Pillez A., Wychowski C., Blight K., Xu J., Hahn Y. S., Rice C. M., Dubuisson J. Formation of native hepatitis C virus glycoprotein complexes. J. Virol. 71:1997;697-704.
16. Desgranges C., Boyer V., Souche S., Sprecher S., Burny A., Gallo R. C., Bernard J., Reveil B., Zagury D. Monoclonal antibodies to HIV in a non-infected, immunized volunteer. Lancet. 8591:1988;935-936.
17. Dubuisson J., Hsu H. H., Cheung R. C., Greenberg H. B., Russell D. G., Rice C. M. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and sindbis viruses. J. Virol. 68:1994;6147-6160.
18. Dubuisson J., Rice C. M. Hepatitis C virus glycoprotein folding: Disulfide bond formation and association with calnexin. J. Virol. 70:1996;778-776.
19. Emini E. A., Schleif W. A., Nunberg J. H., Conley A. J., Eda Y., Tokiyoshi S., Putney S. D., Matsushita S., Cobb K. E., Jett C. M., Eichberg J. W., Murphy K. K. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature. 355:1992;728-730.
20. Farci P., Alter H. J., Wong D. C., Miller R. H., Govindarajan S., Engle R., Shapiro M., Purcell R. H. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA. 91:1994;7792-7796.
21. Farci P., Shimoda A., Wong D., Cabezon T., De Gioannis D., Strazzera A., Shimizu Y., Shapiro M., Alter H. J., Purcell R. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. USA. 93:1996;15394-15399.
22. Fournillier-Jacob A., Cahour A. Escriou N., Girard M., Wychowski C. Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells. J. Gen. Virol. 77:1996a;1055-1064.
23. Fournillier-Jacob A., Lunel F., Cahour A., Cresta P., Frangeul L., Perrin M., Girard M., Wychowski C. Antibody responses to hepatitis C virus proteins in patients with acute or chronic hepatitis C. J. Med. Virol. 50:1996b;159-167.
24. Fouts T.R, Binley J. M., Trkola A., Robinson J. E., Moore J. P. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71:1997;2779-2785.
25. Francki R. I. B., Fauquet C. M., Knudson D. L., Brown F. Classification and nomenclature of viruses: Fifth report of the International Committee on Taxonomy of Viruses. Arch. Virol. Suppl. 2:1991;223-233.
26. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient expression system based on recombinant vaccinia virus that synthezises bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 93:1986;8122-8126.
27. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1993;1385-1395.
28. Hsu H. H., Donets M., Greenberg H. B., Feinstone S. M. Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system. Hepatology. 17:1993;763-771.
29. Lanford R. E., Notvall L., Chavez D., White R., Frenzel G., Simonsen C., Kim J. Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology. 197:1993;225-235.
30. Lesniewski R., Okasinski G., Carrick R., Van Sant C., Desai S., Johnson R., Scheffel J., Moore B., Mushawar I. Antibody to hepatitis C virus second envelope (HCV E2) glycoprotein: A new marker of HCV infection closely associated with viremia. J. Med. Virol. 45:1995;415-422.
31. Major M. E., Vitvitski L., Mink M. A., Schleef M., Whalen R. G., Trépo C., Inchauspé G. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69:1995;5798-5805.
32. Michalak J.-P., Wychowski C., Choukhi A., Meunier J.-C., Ung S., Rice C. M., Dubuisson J. Characterization of truncated forms of hepatitis C glycoproteins. J. Gen. Virol. 78:1997;2299-2306.
33. Miller R. H., Purcell R. H. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc. Natl. Acad. Sci. USA. 87:1990;2057-2061.
34. Miyamura T., Matsuura Y. Structural proteins of hepatitis C virus. Trends Microbiol. 1:1993;229-231.
35. Mondelli M. U., Cerino A., Boender P., Oudshoorn P., Middledorp J., Fipaldini C., la Monica N., Habets W. Significance of the immune response to a major conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J. Virol. 68:1994;4829-4836.
36. Nakano I., Maertens G., Major. M. E., Vitviski L., Dubuisson J., Fournillier A., De Martynoff G., Trépo C., Inchauspé G. Immunization with plasmid encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J. Virol. 71:1997;7101-7109.
37. Putkonen P., Thorstensson R., Ghavamzadeh L., Albert J., Hild K., Biberfeld G., Norrby E. Prevention of HIV-2 and SIVsm infection by passive immunization in cynomologous monkeys. Nature. 352:1991;436-438.
38. Ralston R., Thudium K., Berger K., Kuo C., Gervase B., Hall J., Selby M., Kuo G., Houghton M., Choo Q.-L. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J. Virol. 67:1993;6753-6761.
39. Rice, C. M. 1996, Flaviviridae: The viruses and their replication, In, Fields Virology, 931, 959, Raven Press, New York.
40. Rosa D., Campagnoli S., Moretto C., Guenzi E., Cousens L., Chin M., Dong C., Weiner A. J., Lau J. Y. N., Choo Q.-L., Chien D., Pileri P., Houghton M., Abrignani S. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA. 93:1996;1759-1763.
41. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kituchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q.-L., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
42. Sambrook, J. Fritsh, E. F. Maniatis, T. 1989, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
43. Seigneurin J. M., Desgranges C., Seigneurin D., Paire J., Renversez J. C., Jacquemont B., Micouin C. Herpes simplex glycoprotein D: Human monoclonal antibody produced by bone marrow cell line. Science. 221:1983;173-175.
44. Selby M. J., Choo Q.-L., Berger K., Kuo G., Glazer E., Eckart M., Lee C., Chien D., Kuo C., Houghton M. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C virus genome. J. Gen. Virol. 74:1993;1103-1113.
45. Shimizu Y. K., Hijikata M., Iwamoto A., Alter H. J., Purcell R. H., Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68:1994;1494-1500.
46. Shimizu Y. K., Igarashi H., Kiyohara T., Cabezon T., Farci P., Purcell R. H., Yoshikura H. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology. 223:1996;409-412.
47. Wang Y.-F., Brotman B., Andrus L., Prince A. M. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees. J. Infect. Dis. 173:1996;808-821.
48. Weiner A. J., Brauer M. J., Rosenblatt J., Richman K. H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q.-L., Houghton M., Han J. H. Variable and hypervariable domains are found in the regions of HCV corresponding to flavivirus envelope and NS1 proteins and the pestivirus envelope proteins. Virology. 180:1991;842-848.
49. Wychowski C., Benichou D., Girard M. A domain of SV40 capsid polypeptide VP1 that specifies migration into the cell nucleus. EMBO J. 5:1986;2569-2576.
50. Zibert A., Meisel H., Kraas W., Schulz A., Jung G., Roggendorf M. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology. 25:1997;1245-1249.
51. Zibert A., Schreier E., Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology. 208:1995;653-661.